MiR-374a Activates Wnt/β-Catenin Signaling to Promote Osteosarcoma Cell Migration by Targeting WIF-1

  • Weichao Li
  • Zengdong Meng
  • Tiannan Zou
  • Gang Wang
  • Yijing Su
  • Shaoping YaoEmail author
  • Xianrun SunEmail author
Original Article


MiR-374a was proved to take part in the initiation and development of several cancers. However, the molecular mechanism of miR-374a in osteosarcoma (OS) cells remains unclear. The aim of our research was to investigate the role of miR-374a in OS cells migration and clarify the potential mechanisms. Quantitative real-time PCR (qRT-PCR) and western blot analysis were applied to evaluate the expression of miR-374a and Wnt inhibitory factor-1 (WIF-1). Bioinformatical methods and luciferase reporter assay were carried out to predict and confirm the combination of miR-374a and WIF-1. Transwell and wound healing assays were performed to detect the migration capacity of OS cells. Lithium chloride (LiCl) was used to investigate the role of LiCl-activated Wnt/β-catenin signaling pathway in regulating cell migration. Our studies revealed that miR-374a was up-regulated whereas WIF-1 was down-regulated in OS cells. Besides, WIF-1 was the target of miR-374a by performing luciferase reporter assay. By transfection of miR-374a inhibitor and/or WIF-1 siRNA to OS cells, we found that miR-374a promoted the migration of OS cells. In addition, the inhibition of WIF-1 abolished the miR-374a inhibitor-induced migration suppression of OS cells. LiCl experiment revealed that miR-374a promoted OS cells migration by regulating Wnt/β-catenin signaling. In conclusion, miR-374a promotes OS cells migration by activating Wnt/β-catenin signaling pathway via targeting WIF-1.


Osteosarcoma (OS) miR-374a Migration Wnt inhibitory factor-1 (WIF-1) Wnt/β-catenin Signaling pathway 



This work was supported the Development Program of Kunming University of Science and Technology (Grant No.: KKSY201560051), Yunnan Provincial Science and Technology Department-Kunming Medical University Joint Special Project (Grant No.: 2015FB095) and the Basic Research Project of Yunnan Provincial Science and Technology (Grant No.: 2018FB119).

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflict of interest.


  1. 1.
    Misaghi A, Goldin A, Awad M, Kulidjian AA (2018) Osteosarcoma: a comprehensive review. SICOT J 4:12CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Namlos HM, Meza-Zepeda LA, Baroy T, Ostensen IH, Kresse SH, Kuijjer ML, Serra M, Burger H, Cleton-Jansen AM, Myklebost O (2012) Modulation of the osteosarcoma expression phenotype by microRNAs. PLoS One 7:e48086CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Kumar R, Kumar M, Malhotra K, Patel S (2018) Primary osteosarcoma in the elderly revisited: current concepts in diagnosis and treatment. Curr Oncol Rep 20:13CrossRefPubMedGoogle Scholar
  4. 4.
    Simpson S, Dunning MD, de Brot S, Grau-Roma L, Mongan NP, Rutland CS (2017) Comparative review of human and canine osteosarcoma: morphology, epidemiology, prognosis, treatment and genetics. Acta Vet Scand 59:71CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Zhang Y, Yang Q, Wang S (2014) MicroRNAs: a new key in lung cancer. Cancer Chemother Pharmacol 74:1105–1111CrossRefPubMedGoogle Scholar
  6. 6.
    Yang X, Wang L, Wang Q, Li L, Fu Y, Sun J (2018) MiR-183 inhibits osteosarcoma cell growth and invasion by regulating LRP6-Wnt/beta-catenin signaling pathway. Biochem Biophys Res Commun 496:1197–1203CrossRefPubMedGoogle Scholar
  7. 7.
    Yang Z, Li X, Yang Y, He Z, Qu X, Zhang Y (2016) Long noncoding RNAs in the progression, metastasis, and prognosis of osteosarcoma. Cell Death Dis 7:e2389CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Chen Y, Jiang J, Zhao M, Luo X, Liang Z, Zhen Y, Fu Q, Deng X, Lin X, Li L (2016) microRNA-374a suppresses colon cancer progression by directly reducing CCND1 to inactivate the PI3K/AKT pathway. Oncotarget 7:41306–41319PubMedPubMedCentralGoogle Scholar
  9. 9.
    Cai J, Guan H, Fang L, Yang Y, Zhu X, Yuan J, Wu J, Li M (2013) MicroRNA-374a activates Wnt/beta-catenin signaling to promote breast cancer metastasis. J Clin Invest 123:566–579CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Wang Y, Xin H, Han Z, Sun H, Gao N, Yu H (2015) MicroRNA-374a promotes esophageal cancer cell proliferation via Axin2 suppression. Oncol Rep 34:1988–1994CrossRefPubMedGoogle Scholar
  11. 11.
    Lee SH, Koo BS, Kim JM, Huang S, Rho YS, Bae WJ, Kang HJ, Kim YS, Moon JH, Lim YC (2014) Wnt/beta-catenin signalling maintains self-renewal and tumourigenicity of head and neck squamous cell carcinoma stem-like cells by activating Oct4. J Pathol 234:99–107CrossRefPubMedGoogle Scholar
  12. 12.
    Mohammed MK, Shao C, Wang J, Wei Q, Wang X, Collier Z, Tang S, Liu H, Zhang F, Huang J, Guo D, Lu M, Liu F, Liu J, Ma C, Shi LL, Athiviraham A, He TC, Lee MJ (2016) Wnt/beta-catenin signaling plays an ever-expanding role in stem cell self-renewal, tumorigenesis and cancer chemoresistance. Genes Dis 3:11–40CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Yang F, Zeng Q, Yu G, Li S, Wang CY (2006) Wnt/beta-catenin signaling inhibits death receptor-mediated apoptosis and promotes invasive growth of HNSCC. Cell Signal 18:679–687CrossRefPubMedGoogle Scholar
  14. 14.
    Lin B, Hong H, Jiang X, Li C, Zhu S, Tang N, Wang X, She F, Chen Y (2017) WNT inhibitory factor 1 promoter hypermethylation is an early event during gallbladder cancer tumorigenesis that predicts poor survival. Gene 622:42–49CrossRefPubMedGoogle Scholar
  15. 15.
    Tang Q, Zhao H, Yang B, Li L, Shi Q, Jiang C, Liu H (2017) WIF-1 gene inhibition and Wnt signal transduction pathway activation in NSCLC tumorigenesis. Oncol Lett 13:1183–1188CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Malinauskas T, Aricescu AR, Lu W, Siebold C, Jones EY (2011) Modular mechanism of Wnt signaling inhibition by Wnt inhibitory factor 1. Nat Struct Mol Biol 18:886–893CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Huang Y, Du Q, Wu W, She F, Chen Y (2016) Rescued expression of WIF-1 in gallbladder cancer inhibits tumor growth and induces tumor cell apoptosis with altered expression of proteins. Mol Med Rep 14:2573–2581CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Ma Y, Zhu B, Liu X, Yu H, Yong L, Liu X, Shao J, Liu Z (2015) Inhibition of oleandrin on the proliferation show and invasion of osteosarcoma cells in vitro by suppressing Wnt/beta-catenin signaling pathway. J Exp Clin Cancer Res 34:115CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Yu M, Guo D, Cao Z, Xiao L, Wang G (2018) Inhibitory effect of MicroRNA-107 on osteosarcoma malignancy through regulation of Wnt/beta-catenin signaling in vitro. Cancer Investig 36:175–184CrossRefGoogle Scholar
  20. 20.
    Jiang Z, Jiang C, Fang J (2018) Up-regulated lnc-SNHG1 contributes to osteosarcoma progression through sequestration of miR-577 and activation of WNT2B/Wnt/beta-catenin pathway. Biochem Biophys Res Commun 495:238–245CrossRefPubMedGoogle Scholar
  21. 21.
    Poos K, Smida J, Maugg D, Eckstein G, Baumhoer D, Nathrath M, Korsching E (2015) Genomic heterogeneity of osteosarcoma - shift from single candidates to functional modules. PLoS One 10:e0123082CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Li X, Lu Q, Xie W, Wang Y, Wang G (2018) Anti-tumor effects of triptolide on angiogenesis and cell apoptosis in osteosarcoma cells by inducing autophagy via repressing Wnt/beta-catenin signaling. Biochem Biophys Res Commun 496:443–449CrossRefPubMedGoogle Scholar
  23. 23.
    He W, Feng L, Xia D, Han N (2014) MiR-374a promotes the proliferation of human osteosarcoma by downregulating FOXO1 expression. Int J Clin Exp Med 8:3482–3489Google Scholar
  24. 24.
    Yiyu Chen JJ, Zhao M, Luo X, Liang Z, Zhen Y, Qiaofen F, Deng X, Lin X, Li L, Luo R, Liu Z, Fang W (2016) microRNA-374a suppresses colon cancer progression by directly reducing CCND1 to inactivate the PI3K/AKT pathway. Oncotarget 7:41306–41319PubMedPubMedCentralGoogle Scholar
  25. 25.
    Vosa U, Vooder T, Kolde R, Fischer K, Valk K, Tonisson N, Roosipuu R, Vilo J, Metspalu A, Annilo T (2011) Identification of miR-374a as a prognostic marker for survival in patients with early-stage nonsmall cell lung cancer. Genes Chromosomes Cancer 50:812–822CrossRefPubMedGoogle Scholar
  26. 26.
    Wei B, Guo Y, Zhai J, Su J, Han L, Kang C, Zhang Q (2013) A study of the relationship between the Wnt/beta-catenin signaling pathway and the gastrointestinal development of rat embryonic and perinatal periods. Exp Ther Med 5:1598–1602CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Tang L, Wang D, Gu D (2018) Knockdown of Sox2 inhibits OS cells invasion and migration via modulating Wnt/beta-catenin signaling pathway. Pathol Oncol Res 24:907–913CrossRefPubMedGoogle Scholar

Copyright information

© Arányi Lajos Foundation 2018

Authors and Affiliations

  1. 1.Faculty of Medical ScienceKunming University of Science and TechnologyKunmingChina
  2. 2.Department of Orthopedic Surgery, The First People’s Hospital of Yunnan ProvinceAffiliated Hospital of Kunming University of Science and TechnologyKunmingChina

Personalised recommendations